Search hospitals
>
Texas
>
Bryan
Saint Joseph Regional Cancer Center
Claim this profile
Bryan, Texas 77802
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
164 reported clinical trials
2 medical researchers
Summary
Saint Joseph Regional Cancer Center is a medical facility located in Bryan, Texas. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Saint Joseph Regional Cancer Center is involved with conducting 164 clinical trials across 333 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.
Area of expertise
Lung Cancer
Saint Joseph Regional Cancer Center has run 29 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Saint Joseph Regional Cancer Center has run 26 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Richard L. Deming
Mercy Medical Center - Des Moines
7 years of reported clinical research
Mehmet S. Copur
Bethesda North Hospital
13 years of reported clinical research
Clinical Trials running at Saint Joseph Regional Cancer Center
Bladder Cancer
Lung Cancer
Bladder Carcinoma
Prostate Cancer
Multiple Myeloma
Testicular cancer
Melanoma
Lymphoma
Breast cancer
Pancreatic Cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting
1 award
Phase 2
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting
1 award
N/A
9 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Joseph Regional Cancer Center?
Saint Joseph Regional Cancer Center is a medical facility located in Bryan, Texas. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Saint Joseph Regional Cancer Center is involved with conducting 164 clinical trials across 333 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.